Technology Transfer Fee. Within thirty (30) days of the Completion of Technology Transfer, Kiniksa shall pay Biogen a one-time, non-refundable, non-creditable technology transfer fee in the amount of Five Hundred Thousand Dollars ($500,000) (the “Technology Transfer Fee”), payable by electronic funds transfer of immediately available funds to an account or accounts specified to Kiniksa by Biogen in writing at least five (5) Business Days prior to the date thereof.
Appears in 3 contracts
Sources: Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.), Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.), Asset Purchase Agreement (Kiniksa Pharmaceuticals, Ltd.)